Home - Products - Cell Cycle/DNA Damage - DNA Alkylator - Chloroambucil

Chloroambucil

CAS No. 305-03-3

Chloroambucil ( CB-1348; NCI 3088; NSC 3088 )

Catalog No. M13968 CAS No. 305-03-3

Chlorambucil(WR-139013; CB-1348) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia.

Purity : >98%(HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	45	In Stock
50MG	57	In Stock
100MG	91	In Stock
200MG	130	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Chloroambucil
Note

Research use only, not for human use.
Brief Description

Chlorambucil(WR-139013; CB-1348) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia.
Description

Chlorambucil(WR-139013; CB-1348) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia.
Synonyms

CB-1348; NCI 3088; NSC 3088
Pathway

Cell Cycle/DNA Damage
Target

DNA Alkylator
Recptor

DNA Alkylation
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

305-03-3
Formula Weight

304.22
Molecular Formula

C14H19Cl2NO2
Purity

>98%(HPLC)
Solubility

Ethanol: 60 mg/mL (197.23 mM); DMSO: 60 mg/mL (197.23 mM)
SMILES

O=C(O)CCCC1=CC=C(N(CCCl)CCCl)C=C1
Chemical Name

4-(4-(bis(2-chloroethyl)amino)phenyl)butanoic acid

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Kashiwazaki G, et al. Bioorg Med Chem. 2010 Apr 15;18(8):2887-93.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Bisantrene

A small molecule DNA intercalater with antineoplastic activity, does not exhibit cardiotoxicity compared with doxorubicin; induces both protein-associated DNA single-strand breaks and DNA-protein crosslinks in cancer cells.
Streptozocin

Streptozotocin is a DNA alkylating agent that enters cells exclusively via the GLUT2 glucose transport protein.
KCC-07

KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.

Sign In Join Free